Strength
40 mg/1
Manufacturer
AvPAKNDC
50268081212
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ZIPRASIDONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077561On Market Since
5/12/2021
Pharmacological Classes
Price Statistics
The NADAC for ZIPRASIDONE HCL 40 MG CAPSULE has been published 250 times since Sep 15, 2021, and over the history we have for it it has declined 9.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2734 per EA |
|---|---|
| All-time high | $0.3117 (Mar 15, 2023) |
| All-time low | $0.1879 (Nov 20, 2024) |
| 52-week high | $0.2786 |
| 52-week low | $0.2490 |
| Median price | $0.2740 |
| Average price | $0.2730 |
| Largest weekly change | +30.8% (Jun 19, 2024) |
| Weeks tracked | 250 |
| Tracking since | Sep 15, 2021 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ZIPRASIDONE HCL 40 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for ZIPRASIDONE HCL 40 MG CAPSULE, manufactured by AvPAK, is $0.2734 per EA (NDC 50268081212), effective Jun 24, 2026.
How has the price of ZIPRASIDONE HCL 40 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for ZIPRASIDONE HCL 40 MG CAPSULE has declined 9.9%. It has been tracked across 250 weekly CMS publications since Sep 15, 2021.
What are the highest and lowest recorded NADAC prices for ZIPRASIDONE HCL 40 MG CAPSULE?
Since Sep 15, 2021, the NADAC for ZIPRASIDONE HCL 40 MG CAPSULE has ranged from a low of $0.1879 (Nov 20, 2024) to a high of $0.3117 (Mar 15, 2023), with a median of $0.2740 per EA.
Are there cheaper alternatives to ZIPRASIDONE HCL 40 MG CAPSULE?
2 NADAC-published products share the same active ingredient, strength, and dosage form as ZIPRASIDONE HCL 40 MG CAPSULE, but none are currently priced below it.
Who manufactures ZIPRASIDONE HCL 40 MG CAPSULE?
ZIPRASIDONE HCL 40 MG CAPSULE (NDC 50268081212) is labeled by AvPAK, and CMS classifies it as a generic product.
Related Drugs
Same classification